Hsp70 in cancer: A double agent in the battle between survival and death

Hsp70 in cancer: A double agent in the battle between survival and death


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: جلال عبدالعلیزاده , ام لیلا مولوی

کلمات کلیدی: antigen presenting cells, cancer vaccines, cytotoxic T cells, exosome, Hsp70 inhibitors, natural killer cell, siRNA

نشریه: 17160 , 5 , 236 , 2020

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله جلال عبدالعلیزاده
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات ایمونولوژی
کد مقاله 74478
عنوان فارسی مقاله Hsp70 in cancer: A double agent in the battle between survival and death
عنوان لاتین مقاله Hsp70 in cancer: A double agent in the battle between survival and death
ناشر 6
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Review Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

The heat shock protein (Hsps) superfamily, also known as molecular chaperones, are highly conserved and present in all living organisms and play vital roles in protein fate. The HspA1A (Hsp70‐1), called Hsp70 in this review, is expressed at low or undetectable levels in most unstressed normal cells, but numerous studies have shown that diverse types of tumor cells express Hsp70 at the plasma membrane that leads to resistance to programmed cell death and tumor progression. Hsp70 is released into the extracellular milieu in three forms including free soluble, complexed with cancer antigenic peptides, and exosome forms. Therefore, it seems to be a promising therapeutic target in human malignancies. However, a great number of studies have indicated that both intracellular and extracellular Hsp70 have a dual function. A line of evidence presented that intracellular Hsp70 has a cytoprotective function via suppression of apoptosis and lysosomal cell death (LCD) as well as that extracellular Hsp70 can promote tumorigenesis and angiogenesis. Other evidence showed intracellular Hsp70 can promote apoptosis and membrane‐associated/ extracellular Hsp70 can elicit antitumor innate and adaptive immune responses. Given the contradictory functions, as a 'double agent,' could Hsp70 be a promising tool in the future of targeted cancer therapies? To answer this question, in this review, we will discuss the functions of Hsp70 in cancers besides inhibition and stimulation strategies for targeting Hsp70 along with their challenges.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
جلال عبدالعلیزادهششم
ام لیلا مولویچهارم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Hsp70incancer A doubleagentinthebattlebetweensurvivaland death.pdf1399/09/023632184دانلود